secwatch.observer — SEC 8-K summary
======================================

Issuer:     DMK PHARMACEUTICALS Corp (—)
CIK:        0000887247
Form:       8-K
Filed at:   2024-07-01T23:59:59+00:00
Accession:  0001999371-24-008002
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 2.01, 5.02
LLM model:  deepseek-v4-flash:cloud@v2

DMK Pharmaceuticals sells ZIMHI assets for $3.17M; entire board and CEO resign effective June 27, 2024
--------------------------------------------------------------------------------

- Sold ZIMHI assets to zmi pharma inc. for $3,170,600 on May 16, 2024, approved by Bankruptcy Court.
- Chairman and CEO Ebrahim Versi resigned as director and CEO effective June 27, 2024.
- All other directors (Birndorf, Desai, Reed, J. Versi) resigned; no disagreements cited.
- General Counsel John Dorbin separated; CFO Seth Cohen named Chief Restructuring Officer.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/887247/000199937124008002/0001999371-24-008002-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/887247/000199937124008002/dmk-8k_051624.htm
  HTML page:      https://secwatch.observer/filing/0001999371-24-008002

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer